Heart Failure, Precision Medicine, and Incremental Equity: The Case of Hereditary Amyloid Cardiomyopathy
Echols and Taylor discuss hereditary amyloid cardiomyopathy. Heart failure is a complex clinical syndrome associated with frequently debilitating and lethal outcomes. Continual advancement in understanding the varied etiologies and specific molecular and mechanical processes underlying heart failure...
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2022-04, Vol.327 (14), p.1341-1343 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Echols and Taylor discuss hereditary amyloid cardiomyopathy. Heart failure is a complex clinical syndrome associated with frequently debilitating and lethal outcomes. Continual advancement in understanding the varied etiologies and specific molecular and mechanical processes underlying heart failure have led to lifesaving advances in the management of this disorder; however, the annual morbidity, mortality, and economic costs related to heart failure remain unacceptably high. Improved care options, including the precise targeting of specific physiological derangements that underlie heart failure pathology, offer hope for an improved outlook for patients. |
---|---|
ISSN: | 0098-7484 1538-3598 |
DOI: | 10.1001/jama.2022.2360 |